OCEAOTCPharmaceutical PreparationsFiscal year ends December 31
Ocean Biomedical, Inc.
Financials through Q1 FY2025, quarter ended Mar 31, 2025Last filing: 10-Q on May 15, 2025
$0.00−0.00 (-16.67%)
Close on Oct 19, 2026
- Market cap
- $45.51K
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.0005 (−50.00%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Mar 31, 2025
Valuation
- Market cap
- $45.51K
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$30.72M
- EPS, diluted
- -$0.91
- Book value per share
- -$1.02
- Diluted shares
- 91M
Four years at a glance
Fiscal years 2021 to 2024 and trailing twelve months, USD
Operating income
-$4.16M
Net income
-$30.72M
EPS, diluted
-$0.91
Reported periodTrailing twelve months